Lymph node metastases were found in 42% (5 out of 12) and 47% (15 out of 32) of ERβ+ and ERβ− patients, respectively, and absent in 58% and 53% of ERβ+ and ERβ− patients, respectively. This evidence concerns the gene ESR2 and metastatic malignant neoplasm in the lymph nodes.